The President of the USA, Donald Trump, promised at a press conference on Thursday that the price of the weight loss medicine Ozempic would be significantly reduced in the USA.
This makes the company's share fall on the Copenhagen Stock Exchange, after lunch the share is down by nearly 6 percent.
Also the American competitor Eli Lilly is falling back, the share is down by around 4 percent in the preliminary negotiations.
